All News Oncotelic Therapeutics, Inc.

Equities

OTLC

US6283411097

Market Closed - OTC Markets Other stock markets 11:42:48 15/05/2024 pm IST			5-day change	1st Jan Change
0.036 ^USD	-7.69%		-8.63%	-6.01%

12/04	Oncotelic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
25/03	Oncotelic Therapeutics, Inc. Announces Linkage of Cancer and Lupus in Gliomas Patients	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024	08/05	AQ
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.	29/04	AQ
Oncotelic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/04	CI
Oncotelic Therapeutics, Inc. - Linkage of Cancer and Lupus in Gliomas Patients	26/03	AQ
Linkage of Cancer and Lupus in Gliomas Patients	25/03	AQ
Oncotelic Therapeutics, Inc. Announces Linkage of Cancer and Lupus in Gliomas Patients	25/03	CI
Invitation to Participate in STOP-PC Clinical Trial	04/03	AQ
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024 (Updated)	21/02	AQ
Oncotelic Therapeutics Announces Clinical Linkage of TGFB2 and IFNGR2 in Pediatric DMG Patients	16/01	AQ
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	22/12	AQ
Oncotelic Therapeutics Announces Opening of GMP Manufacturing Plant	18/12	AQ
Oncotelic Therapeutics Announces CEO to Discuss Proprietary AI Technology at Ibero-American Chatbot Summit	29/11	AQ
Oncotelic Therapeutics Announces CEO To Discuss Proprietary AI Technology at Ibero-American Chatbot Summit.	28/11	AQ
Earnings Flash (OTLC) ONCOTELIC THERAPEUTICS Posts Q3 Revenue $70,000	15/11	MT
Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial Results	15/11	AQ
Oncotelic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Oncotelic Therapeutics, Inc. announces tranche update	24/23/24	CI
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023	28/23/28	AQ
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023	25/23/25	AQ
Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer	23/23/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Oncotelic Therapeutics, Inc.

Equities

OTLC

US6283411097

All News

Filters